Literature DB >> 16123800

Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology.

Gabriella Minchiotti1.   

Abstract

Embryonic stem (ES) cells have provided a valid model to understand early events of mammalian lineage specification and differentiation, leading to important insights into the mechanisms that control embryogenesis at the molecular and cellular levels. Furthermore, ES cells have recently evoked great scientific interest as ideal candidates for the generation of tissues for transplantation therapies. In this respect, particular attention has been paid to the molecules and signaling pathways triggering ES cell differentiation. The EGF-CFC Cripto protein is a key regulator of ES cells fate. The cripto gene is expressed both in ES cells and during the early phases of embryo development, while, in the adult, it is reactivated in a wide range of epithelial cancers. This review will discuss recent findings on the molecular basis of Cripto signaling in ES cell differentiation, providing an intriguing link between stem cell and tumor biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123800     DOI: 10.1038/sj.onc.1208917

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis.

Authors:  Peter C Gray; Wylie Vale
Journal:  FEBS Lett       Date:  2012-02-01       Impact factor: 4.124

Review 2.  Nodal morphogens.

Authors:  Alexander F Schier
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11       Impact factor: 10.005

3.  Transforming growth factor β in cancer: Janus, the two-faced god.

Authors:  David Salomon
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 13.506

4.  A sparse differential clustering algorithm for tracing cell type changes via single-cell RNA-sequencing data.

Authors:  Martin Barron; Siyuan Zhang; Jun Li
Journal:  Nucleic Acids Res       Date:  2018-02-16       Impact factor: 16.971

5.  Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy.

Authors:  S Kim; Y M Yoon; Y-S Han; J H Lee; J Hur; S H Lee
Journal:  Cell Prolif       Date:  2018-05-02       Impact factor: 6.831

6.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

7.  Cripto-1 is required for hypoxia to induce cardiac differentiation of mouse embryonic stem cells.

Authors:  Caterina Bianco; Catherine Cotten; Enza Lonardo; Luigi Strizzi; Christina Baraty; Mario Mancino; Monica Gonzales; Kazuhide Watanabe; Tadahiro Nagaoka; Colin Berry; Andrew E Arai; Gabriella Minchiotti; David S Salomon
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

8.  Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.

Authors:  J A Kelber; A D Panopoulos; G Shani; E C Booker; J C Belmonte; W W Vale; P C Gray
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

9.  Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.

Authors:  Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Dawn A Kirschmann; Alina Lipavsky; William W Wheaton; Daniel E Abbott; Richard E B Seftor; Mary J C Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

10.  Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin.

Authors:  Ombretta Guardiola; Peggy Lafuste; Silvia Brunelli; Salvatore Iaconis; Thierry Touvier; Philippos Mourikis; Katrien De Bock; Enza Lonardo; Gennaro Andolfi; Ann Bouché; Giovanna L Liguori; Michael M Shen; Shahragim Tajbakhsh; Giulio Cossu; Peter Carmeliet; Gabriella Minchiotti
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.